Forte Biosciences, Inc.
A clinical-stage biopharma firm developing treatments for autoimmune-related diseases.
FBRX | US
Overview
Corporate Details
- ISIN(s):
- US8888461022 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 3060 PEGASUS PARK DRIVE, 75247 DALLAS
- Sector:
- Manufacturing
Description
Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for autoimmune and autoimmune-related diseases. The company's lead product candidate is FB-102, a proprietary molecule with potentially broad applications. Forte is advancing FB-102 through clinical trials for several indications, including celiac disease, vitiligo, and alopecia areata.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Forte Biosciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Forte Biosciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Forte Biosciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
